These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 23083656)
1. Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. Helfand BT; Lee JY; Sharp V; Foster H; Naslund M; Williams OD; McVary KT; J Urol; 2012 Dec; 188(6):2288-93. PubMed ID: 23083656 [TBL] [Abstract][Full Text] [Related]
2. The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial. Helfand BT; McVary KT; Meleth S; Sharp V; Foster H; Naslund M; Williams OD; J Urol; 2011 Jun; 185(6):2223-8. PubMed ID: 21497839 [TBL] [Abstract][Full Text] [Related]
5. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. Barry MJ; Meleth S; Lee JY; Kreder KJ; Avins AL; Nickel JC; Roehrborn CG; Crawford ED; Foster HE; Kaplan SA; McCullough A; Andriole GL; Naslund MJ; Williams OD; Kusek JW; Meyers CM; Betz JM; Cantor A; McVary KT; JAMA; 2011 Sep; 306(12):1344-51. PubMed ID: 21954478 [TBL] [Abstract][Full Text] [Related]
6. Serenoa repens for benign prostatic hyperplasia. Wilt T; Ishani A; Mac Donald R Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626 [TBL] [Abstract][Full Text] [Related]
7. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408 [TBL] [Abstract][Full Text] [Related]
8. Phytotherapy for benign prostatic hyperplasia. Wilt TJ; Ishani A; Rutks I; MacDonald R Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294 [TBL] [Abstract][Full Text] [Related]
9. Safety and toxicity of saw palmetto in the CAMUS trial. Avins AL; Lee JY; Meyers CM; Barry MJ; J Urol; 2013 Apr; 189(4):1415-20. PubMed ID: 23063633 [TBL] [Abstract][Full Text] [Related]
10. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine. Ooi SL; Pak SC J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684 [TBL] [Abstract][Full Text] [Related]
11. Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia. Lee JY; Foster HE; McVary KT; Meleth S; Stavris K; Downey J; Kusek JW J Altern Complement Med; 2011 May; 17(5):469-72. PubMed ID: 21554128 [TBL] [Abstract][Full Text] [Related]
12. The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial. Andriole GL; McCullum-Hill C; Sandhu GS; Crawford ED; Barry MJ; Cantor A; J Urol; 2013 Feb; 189(2):486-92. PubMed ID: 23253958 [TBL] [Abstract][Full Text] [Related]
13. An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study. Cai T; Morgia G; Carrieri G; Terrone C; Imbimbo C; Verze P; Mirone V; Arch Ital Urol Androl; 2013 Dec; 85(4):184-9. PubMed ID: 24399119 [TBL] [Abstract][Full Text] [Related]
14. Mirabegron improves sleep measures, nocturia, and lower urinary tract symptoms in those with urinary symptoms associated with disordered sleep. Petrossian RA; Dynda D; Delfino K; El-Zawahry A; McVary KT Can J Urol; 2020 Feb; 27(1):10106-10117. PubMed ID: 32065868 [TBL] [Abstract][Full Text] [Related]
15. Saw palmetto for benign prostatic hyperplasia. Bent S; Kane C; Shinohara K; Neuhaus J; Hudes ES; Goldberg H; Avins AL N Engl J Med; 2006 Feb; 354(6):557-66. PubMed ID: 16467543 [TBL] [Abstract][Full Text] [Related]
17. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264 [TBL] [Abstract][Full Text] [Related]
18. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400 [TBL] [Abstract][Full Text] [Related]
19. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. Barry MJ; Cantor A; Roehrborn CG; J Urol; 2013 Mar; 189(3):987-92. PubMed ID: 23017510 [TBL] [Abstract][Full Text] [Related]
20. Saw Palmetto for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Hammer NC; Thiede J Am Fam Physician; 2024 May; 109(5):396-397. PubMed ID: 38804752 [No Abstract] [Full Text] [Related] [Next] [New Search]